Based on the Pharmadrug Inc. stock forecast from 0 analysts, the average analyst target price for Pharmadrug Inc. is not available over the next 12 months. Pharmadrug Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Pharmadrug Inc. is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Pharmadrug Inc.’s stock price was CAD 0.01. Pharmadrug Inc.’s stock price has changed by +0.00% over the past week, -33.33% over the past month and -81.82% over the last year.
No recent analyst target price found for Pharmadrug Inc.
No recent average analyst rating found for Pharmadrug Inc.
Company Overview Pharmadrug Inc.
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. The company also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and research and development activities in the psychedelics space for the treatment of non-neuropsychiatric conditions. It has a license agreement with Southwest Research Institute. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. is based in Toronto, Canada. Read Less
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. The company also engages in the res...Read More
Frequently Asked Questions About Pharmadrug Inc. (PHRX:CA) Stock
Stock Target Advisor's fundamental analysis for Pharmadrug Inc.'s stock is Bearish.
Unfortunately we do not have enough data on PHRX:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on PHRX:CA's stock to indicate what its average analyst target is.
PHRX:CA stock's Price/Earning ratio is 1.00.
Our analysis grades PHRX:CA stock's Price / Earning ratio at F. This means that PHRX:CA stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the CNSX exchange.
Based on this PHRX:CA may be fairly valued for its sector
The last closing price of PHRX:CA's stock was CAD 0.01.
The most recent market capitalization for PHRX:CA is CAD 1.62M.
Unfortunately we do not have enough analyst data on PHRX:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pharmadrug Inc.'s stock.
As per our most recent records Pharmadrug Inc. has 0 Employees.
Pharmadrug Inc.'s registered address is 77 King Street West, Toronto, ON, Canada, M5K 1H1.
You can get more information about it from Pharmadrug Inc.'s website at https://www.pharmadrug.ca.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Pharmadrug Inc. (PHRX:CA) Stock
Stock Target Advisor's fundamental analysis for Pharmadrug Inc.'s stock is Bearish.
Unfortunately we do not have enough data on PHRX:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on PHRX:CA's stock to indicate what its average analyst target is.
PHRX:CA stock's Price/Earning ratio is 1.00.
Our analysis grades PHRX:CA stock's Price / Earning ratio at F. This means that PHRX:CA stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the CNSX exchange.
Based on this PHRX:CA may be fairly valued for its sector
The last closing price of PHRX:CA's stock was CAD 0.01.
The most recent market capitalization for PHRX:CA is CAD 1.62M.
Unfortunately we do not have enough analyst data on PHRX:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Pharmadrug Inc.'s stock.
As per our most recent records Pharmadrug Inc. has 0 Employees.
Pharmadrug Inc.'s registered address is 77 King Street West, Toronto, ON, Canada, M5K 1H1.
You can get more information about it from Pharmadrug Inc.'s website at https://www.pharmadrug.ca.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PHRX:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
